GINA MARIE CHIPLONIA-SWIRCEK

Physician Assistants & Advanced Practice Nursing Providers|Nurse Anesthetist, Certified Registered ALLENTOWN, PA NPI 1063480101

General Payments — all program years on this page

$617.32

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 31
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $292.57 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $292.5714

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $230.2011
Lilly USA, LLC $23.481
Janssen Biotech, Inc. $21.581
Ardelyx, Inc. $17.311

By program year

Program yearAmountRecords
2021 $92.744
2022 $47.813
2023 $184.2010
2024 $292.5714

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078550129 Janssen Biotech, Inc. $21.58 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135661005 Lilly USA, LLC $23.48 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137725342 Takeda Pharmaceuticals U.S.A., Inc. $16.91 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137725344 Takeda Pharmaceuticals U.S.A., Inc. $20.78 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137725346 Takeda Pharmaceuticals U.S.A., Inc. $14.18 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137725348 Takeda Pharmaceuticals U.S.A., Inc. $27.58 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137725350 Takeda Pharmaceuticals U.S.A., Inc. $16.45 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137725352 Takeda Pharmaceuticals U.S.A., Inc. $22.80 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137725354 Takeda Pharmaceuticals U.S.A., Inc. $21.81 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137725356 Takeda Pharmaceuticals U.S.A., Inc. $20.84 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137725358 Takeda Pharmaceuticals U.S.A., Inc. $28.34 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137725360 Takeda Pharmaceuticals U.S.A., Inc. $23.24 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137725362 Takeda Pharmaceuticals U.S.A., Inc. $17.27 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146721793 Ardelyx, Inc. $17.31 10/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.